New injection site tested for cancer drug to ease patient pain
NCT ID NCT07075510
Summary
This study is testing if giving an approved drug called daratumumab as an injection under the skin of the thigh works as well as the standard injection in the abdomen. The goal is to see if the thigh is a safe and effective alternative for patients who find abdomen injections too painful or difficult. About 30 adults with certain plasma cell disorders, like multiple myeloma, will participate to compare side effects and drug levels from the two injection sites.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLASMA CELL DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Maryland Greenebaum Comprehensive Cancer Center
RECRUITINGBaltimore, Maryland, 21201, United States
Contact
Conditions
Explore the condition pages connected to this study.